AGY — Allergy Therapeutics Share News
0.000.00%
Last trade - 00:00- £393.23m
- £416.07m
- £55.20m
REG - Allergy Therapeutics - Allergy to resume UK manufacturing production
AnnouncementREG - Allergy Therapeutics - Holding(s) in Company
AnnouncementREG - AIM - AIM Notice - 19/10/2022
AnnouncementREG - Allergy Therapeutics - Allergy Therapeutics – Result of GM
AnnouncementREG - Allergy Therapeutics - UK manufacturing update
AnnouncementRCS - Allergy Therapeutics - Allergy Therapeutics at Investor Meet Company
AnnouncementREG - Allergy Therapeutics - Unaudited Preliminary Results 2022
AnnouncementREG - Allergy Therapeutics - Subscription and Debt Financing
AnnouncementRCS - Allergy Therapeutics - Allergy Therapeutics at H.C. Wainwright Conference
AnnouncementREG - Allergy Therapeutics - Total Voting Rights
AnnouncementREG - Allergy Therapeutics - Block Listing Interim Review
AnnouncementREG - Allergy Therapeutics - Trading Update and Notice of Results
AnnouncementRCS - Allergy Therapeutics - Allergy Therapeutics at EAACI Congress 2022
AnnouncementREG - Allergy Therapeutics - Nick Wykeman to step down as CFO
AnnouncementRCS - Allergy Therapeutics - Allergy Therapeutics at H.C. Wainwright Conference
AnnouncementRCS - Allergy Therapeutics - Allergy Therapeutics shares data at WAO-BSACI
AnnouncementRCS - Allergy Therapeutics - Allergy Therapeutics at Cowen Health Conference
AnnouncementRCS - Allergy Therapeutics - Allergy Therapeutics at Investor Meet Company
AnnouncementREG - Allergy Therapeutics - Allergy Therapeutics plc – Interim Results
Announcement